Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2003
11/05/2003CN1453028A Chinese medicine for treating vascular dementia and its prepn
11/05/2003CN1453005A Medicated wine for treating Bi syndrome and prostatitis
11/05/2003CN1453000A Chinese patent medicine for treating apoplexy
11/05/2003CN1452998A Chinese patent medicine for treating coronary heart disease and angina pectoris
11/05/2003CN1452997A Chinese patent medicine for treating coronary heart disease and angina pectoris
11/05/2003CN1452996A Externally applied piles-treating medicine
11/05/2003CN1452991A Cerebral thrombus treating medicine
11/05/2003CN1452986A Leech extractive and its production process and use
11/05/2003CN1452972A Plant extractive composition containing ginkgetin and its use
11/05/2003CN1452971A Composition of gensenoside Rg1 and ferulic acid for preventing and treating cardiac and cerebral vascular diseases and diabetes and its application
11/05/2003CN1452966A Compound Atenolol-Nifedipine slow releasing prepn
11/05/2003CN1452958A Application of all transconfiguration vitamine A acid in preparing medicine for preventing and treating myocardial reconstution
11/05/2003CN1452956A Application of hypocrellin photosensitizer in pharmacy
11/05/2003CN1126564C Application of phospholipid complexes of extracts of civitis vinifera as anti-atherosclerotic agent
11/05/2003CN1126561C Prepn of medicine for treating piles
11/05/2003CN1126551C Chinese herb medicine for treating coronary heart disease
11/05/2003CN1126550C Chinese herb medicine solution for treating anal firstula
11/05/2003CN1126549C Pharmaceutical composition containing nitric oxide
11/05/2003CN1126546C Reduction of infarction region using citicoline
11/05/2003CN1126544C Shuangmidamo suppository and its preparing process
11/05/2003CN1126534C Intracoronary stents fix mould containing quinazolinone derivatives
11/04/2003US6642389 Oxazole derivatives
11/04/2003US6642386 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/04/2003US6642277 And anthocyanin, cardiovascular disorders, inhibits oxidation of plasma LDL, stimulates TGF production and fibrinolysis and is an anticoagulant
11/04/2003US6642267 Side effect reduction over opioid analgesics; analgesic and/or anxiolytic action
11/04/2003US6642264 Thiazolobenzoimidazole derivatives
11/04/2003US6642260 Nitric oxide donors and pharmaceutical compositions containing them
11/04/2003US6642258 Use of central cannabinoid receptor antagonist for preparing medicines
11/04/2003US6642256 Brain disorders, psychological disorders, antiischemic agents, central nervous system disorders
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642250 1,8-naphthyridin-2(1H)-one derivatives
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6642244 Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
11/04/2003US6642242 Quinoline and quinazoline compounds useful in therapy
11/04/2003US6642241 Alkylamino- substituted dihydropyrimido-(4,5-d)pyrimidinone derivatives, inhibitors of p38,
11/04/2003US6642239 Dipeptide nitrile cathepsin K inhibitors
11/04/2003US6642233 Strong affinity and high selectivity for the human NK1 receptors of substance P.
11/04/2003US6642232 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
11/04/2003US6642230 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
11/04/2003US6642228 α1b-adrenergic receptor antagonists
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6642224 Activated blood coagulation factor X inhibitors
11/04/2003US6642223 Benzoheterocyclic derivatives
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/04/2003US6642210 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
11/04/2003US6642026 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
11/04/2003US6642025 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/04/2003US6642010 Identifying, monitoring, and treating women for breast precancer or cancer
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641849 Mixture of L-carnitine, acetyl L-carnitine, and propionyl L-carnitine or salts; cardiovascular, gastrointestinal, sleep, nervous system, and nervous system disorders
11/04/2003US6641839 Isosorbide mononitrate coated sugar or nonpareil core; time-release agents; diffusion control membrane; prevents nitrate tolerance
11/04/2003US6641611 A coating for an intravascular implant that prevents hyperproliferative vascular disease, includes repamyicin as first agent which acts on calcium independent cellular pathway and second agent is cyclosporin A
11/04/2003US6641571 Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
11/04/2003CA2257322C Thiazole derivatives
10/2003
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089934A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1
10/30/2003WO2003089903A2 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003WO2003089638A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof
10/30/2003WO2003089619A2 Placental derived stem cells and uses thereof
10/30/2003WO2003089608A2 Drg11-responsive (dragon) gene family
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003089438A1 Labeled oxazinocarbazoles as diagnostic agents
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089428A1 Tricyclic thrombin receptor antagonists
10/30/2003WO2003089418A1 Indane acetic acid derivatives and their use as pharmaceutical agents
10/30/2003WO2003089417A1 Novel crystalline forms of (s)-n-(1-carboxy-2-methyl-prop-1-yl) -n-pentanoyl-n- [2’-(1h-tetrazol-5-yl-)- biphenyl-4-yl methyl] amine (valsartan)
10/30/2003WO2003089414A1 Amlodipine nicotinate and process for the preparation thereof
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003089409A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy
10/30/2003WO2003089005A1 Drugs for treating vascular diseases
10/30/2003WO2003088992A1 Novel screening method
10/30/2003WO2003088982A1 Device and method for treating restenosis with zinc
10/30/2003WO2003088978A1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088971A1 Combination therapy for the treatment of cancer
10/30/2003WO2003088967A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003WO2003088956A1 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
10/30/2003WO2003088955A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amine and lactic acid or a lactic acid salt
10/30/2003WO2003088945A1 Aerosol containing a particulate active substance
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/30/2003WO2003088905A2 Compositions and minimally invasive methods for treating incomplete tissue repair
10/30/2003WO2003088903A2 Compounds, compositions, and methods
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003088749A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003066629A3 Heteroaryl compounds useful as inhibitors of gsk-3
10/30/2003WO2003063796A3 Heterocyclic arylsulfonamidobenzylic compounds
10/30/2003WO2003053353A3 Administration of vasopeptidase inhibitors to reduce pulse pressure
10/30/2003WO2003053330A3 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3
10/30/2003WO2003052095A3 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
10/30/2003WO2003051831A3 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003047603A3 Breathable gas mixtures to change body temperature
10/30/2003WO2003045404A3 Treatment and diagnosis of diseases associated with adverse levels of zinc, cadmium and calcium
10/30/2003WO2003045319A3 Targeted therapeutics and uses thereof
10/30/2003WO2003029428A3 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
1 ... 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 ... 1595